Natural Capsules Ltd
Natural Capsules Ltd (NATCAPSUQ) last reported results for the quarter ended Jun 2026, with sales of ₹48.71 crore and net profit of ₹-5.75 crore. The stock last traded at ₹168, a market capitalisation of ₹175 crore. Over the past 52 weeks the stock has ranged between ₹136 and ₹257. Figures are as of 6 Oct 2026 and are not real time.
Natural Capsules Ltd share price and key metrics
- Current price
- ₹168
- Market cap
- ₹175 cr
- Book value
- ₹168
- ROE
- -9.45%
- ROCE
- -4.58%
- Dividend yield
- 0.00%
- 52w high / low
- 257/136
Metrics as of 6 Oct 2026. Not real time.
Track Natural Capsules Ltd
Cruxal reads every Natural Capsules Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Natural Capsules Ltd growth and returns
- 10 Years
- %
- 5 Years
- 19%
- 3 Years
- 3%
- TTM
- 9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -238%
- 10 Years
- 8%
- 5 Years
- 4%
- 3 Years
- -24%
- 1 Year
- -33%
- 10 Years
- %
- 5 Years
- 3%
- 3 Years
- -2%
- Last Year
- -9%
Natural Capsules Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹48.71 cr, up 7.8% from ₹45.2 cr a year earlier. Net profit was ₹-5.75 cr, down 3.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 41.22 | 43.83 | 44.97 | 45.2 | 45.8 | 37.75 | 58.45 | 48.71 |
| Expenses | 36.72 | 39.56 | 40.58 | 44.88 | 46.69 | 40.07 | 57.12 | 47.59 |
| Operating profit | 4.5 | 4.27 | 4.39 | 0.32 | -0.89 | -2.32 | 1.33 | 1.12 |
| OPM % | 10.92% | 9.74% | 9.76% | 0.71% | -1.94% | -6.15% | 2.28% | 2.30% |
| Other income | 0.11 | 0.11 | 0.3 | 0.36 | 0.16 | 0.45 | 0.76 | 2.35 |
| Interest | 1.65 | 1.54 | 1.64 | 2.53 | 2.68 | 2.85 | 2.89 | 4.97 |
| Depreciation | 2.35 | 2.33 | 2.16 | 4.21 | 4.29 | 4.36 | 4.28 | 4.33 |
| Profit before tax | 0.61 | 0.51 | 0.89 | -6.06 | -7.7 | -9.08 | -5.08 | -5.83 |
| Tax % | 201.64% | 78.43% | 41.57% | -8.09% | -9.09% | -21.70% | -1.97% | -1.54% |
| Net profit | -0.61 | 0.11 | 0.52 | -5.58 | -6.99 | -7.12 | -4.98 | -5.75 |
| EPS (₹) | -0.60 | 0.11 | 0.35 | -5.40 | -6.76 | -4.77 | -3.32 | -3.82 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Natural Capsules Ltd annual results
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 55 | 60 | 62 | 80 | 135 | 170 | 155 | 169 | 187 | 191 |
| Operating profit | 6 | 5 | 5 | 11 | 26 | 35 | 20 | 18 | -1 | -1 |
| OPM % | 10% | 8% | 9% | 14% | 19% | 21% | 13% | 10% | -0.5% | -0.4% |
| Net profit | 1 | 2 | 1 | 7 | 14 | 18 | 6 | 1 | -25 | -25 |
| EPS (₹) | 1.19 | 2.06 | 0.92 | 7.43 | 14.96 | 20.02 | 5.95 | 0.42 | -16.44 | -18.67 |
TTM is the trailing twelve months to the most recent quarter.
Natural Capsules Ltd balance sheet
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 | 6 | 6 | 6 | 7 | 9 | 9 | 10 | 10 |
| Reserves | 48 | 49 | 49 | 56 | 76 | 114 | 194 | 176 | 165 |
| Borrowings | 0 | 5 | 6 | 10 | 53 | 97 | 109 | 152 | 162 |
| Other liabilities | 19 | 14 | 14 | 27 | 29 | 70 | 64 | 81 | 87 |
| Total liabilities | 73 | 75 | 76 | 99 | 165 | 290 | 377 | 419 | 424 |
| Fixed assets | 22 | 24 | 24 | 38 | 66 | 97 | 103 | 284 | 274 |
| CWIP | 1 | 2 | 2 | 7 | 20 | 88 | 144 | 0 | 4 |
| Investments | 5 | 5 | 6 | 0 | 0 | 0 | 3 | 3 | 3 |
| Other assets | 45 | 43 | 45 | 54 | 79 | 105 | 127 | 133 | 143 |
| Total assets | 73 | 75 | 76 | 99 | 165 | 290 | 377 | 419 | 424 |
As reported by the company. Total assets equal total liabilities by construction.
Natural Capsules Ltd cash flow
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 5 | 2 | 7 | 13 | -1 | 17 | -8 | 27 | 11 |
| Cash from investing | -1 | -7 | -6 | -16 | -46 | -105 | -73 | -44 | -11 |
| Cash from financing | -4 | 4 | -1 | 3 | 48 | 87 | 82 | 16 | -1 |
| Net cash flow | 0 | -1 | 0 | -0 | 1 | 0 | 1 | -2 | -0 |
| Free cash flow | 4 | -5 | 2 | -11 | -47 | -88 | -79 | -18 | -1 |
| CFO / operating profit | 97% | 57% | 144% | 134% | 17% | 64% | -32% | 162% | -1,634% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Natural Capsules Ltd operating ratios
| Per year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 5% | 4% | 11% | 21% | 15% | 5% | 3% | -5% |
| Debtor days | 208 | 197 | 180 | 123 | 71 | 112 | 128 | 134 | 139 |
| Inventory days | 149 | 87 | 89 | 82 | 34 | 45 | 88 | 109 | 94 |
| Days payable | 185 | 114 | 91 | 159 | 98 | 127 | 141 | 166 | 197 |
| Cash conversion cycle | 172 | 170 | 179 | 45 | 7 | 30 | 75 | 78 | 36 |
| Working capital days | 186 | 143 | 121 | 35 | 73 | 61 | 80 | 53 | -1 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Natural Capsules Ltd shareholding pattern
Promoters held 50.92% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.59% | 51.13% | 51.21% | 51.26% | 51.26% | 51.26% | 51.04% | 50.92% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 48.39% | 48.86% | 48.80% | 48.75% | 48.73% | 48.74% | 48.96% | 49.09% |
| No. of shareholders | 9,862 | 9,661 | 9,425 | 9,311 | 9,573 | 9,075 | 8,850 | 8,756 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Natural Capsules Ltd corporate filings
- Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit the certificate received from Cameo Corporate Services Limited, Registrar & ....Company Updatelow impact
- We wish to inform that the "Trading Window" for dealing in the equity shares of the company shall remain closed for all Designated Person and their immediate relatives with effect from ....Insider Trading / SASTlow impact
- Natural Capsules Limited shareholders approve preferential issuance of equity shares and convertible warrantsAGM/EGMmedium impact
Cruxal's analysis: Natural Capsules Limited has received shareholder approval via an Extraordinary General…
Read the full analysis - Natural Capsules Limited Concludes EGM to Approve Preferential Allotment of Equity Shares and Convertible WarrantsAGM/EGMmedium impact
Cruxal's analysis: Natural Capsules Limited has successfully conducted its 1st Extraordinary General Meeting…
Read the full analysis - Natural Capsules Limited Issues Corrigendum to EGM Notice Regarding Revised Preferential Issue Pricing and QuantityCompany Updatemedium impact
Cruxal's analysis: Natural Capsules Limited has issued a corrigendum to its Extraordinary General Meeting…
Read the full analysis - Natural Capsules Limited Announces Revised Preferential Issue of Equity Shares and Convertible Warrants to PromoterCompany Updatehigh impact
Cruxal's analysis: Natural Capsules Limited has issued a corrigendum to its EGM notice, revising the terms…
Read the full analysis - Natural Capsules Limited Announces Preferential Issue of Equity Shares and Warrants to Promoter GroupBoard Meetingmedium impact
Cruxal's analysis: Natural Capsules Limited has approved a preferential issue of 1.125 lakh equity shares…
Read the full analysis - Natural Capsules Limited schedules board meeting to revise preferential issue terms following regulatory queriesBoard Meetingmedium impact
Cruxal's analysis: Natural Capsules Limited has announced a board meeting on September 02, 2026, to address…
Read the full analysis - Natural Capsules Limited announces Extraordinary General Meeting (EGM) for September 09, 2026Company Updatelow impact
Cruxal's analysis: Natural Capsules Limited has issued a formal notice regarding the completion of the…
Read the full analysis - Natural Capsules Ltd issues newspaper notice for attention of equity shareholdersCompany Updatelow impact
Cruxal's analysis: Natural Capsules Ltd has published a statutory notice in newspapers to inform equity…
Read the full analysis - Natural Capsules Limited schedules Extraordinary General Meeting for September 9, 2026Corp. Actionlow impact
Cruxal's analysis: Natural Capsules Limited has formally announced an Extraordinary General Meeting (EGM) to…
Read the full analysis - Natural Capsules Limited Announces Preferential Allotment of Equity Shares and Convertible Warrants to PromoterAGM/EGMhigh impact
Cruxal's analysis: Natural Capsules Limited has announced a preferential issue to its promoter, Mr. Sunil…
Read the full analysis - Natural Capsules Limited: Resignation of Independent Director from Material SubsidiaryCompany Updatelow impact
Cruxal's analysis: Natural Capsules Limited has announced the resignation of Mr. Pramod Kasat from his…
Read the full analysis - Natural Capsules Limited Announces Unaudited Financial Results for Quarter Ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Natural Capsules Limited has formally disclosed its unaudited financial results for the…
Read the full analysis - Natural Capsules Limited Announces Successful Conclusion of 33rd Annual General Meeting and Voting ResultsAGM/EGMlow impact
Cruxal's analysis: Natural Capsules Limited has successfully concluded its 33rd Annual General Meeting held…
Read the full analysis - Natural Capsules Limited Reports Q1FY27 Financial Results and Strategic Progress in API SegmentCompany Updatehigh impact
Cruxal's analysis: Natural Capsules Limited reported Q1FY27 consolidated revenue of INR 48.71 crore…
Read the full analysis - Natural Capsules Limited Reports Q1FY27 Financials: Revenue of 48.71 crore with Strategic Pivot in HPMC SegmentCompany Updatemedium impact
Cruxal's analysis: Natural Capsules Limited reported Q1FY27 revenue of 48.71 crore, EBITDA of 1.12 crore…
Read the full analysis - Natural Capsules Limited appoints K. H. Honneshaiah as COO of material subsidiary Natural Biogenex Private LimitedCompany Updatemedium impact
Cruxal's analysis: Natural Capsules Limited has announced the appointment of Mr. K. H. Honneshaiah as the…
Read the full analysis - Natural Capsules Limited Announces Q1 FY27 Financial Results and Promoter-Led Preferential Issue of Equity and WarrantsBoard Meetinghigh impact
Cruxal's analysis: Natural Capsules Limited reported Q1 FY27 standalone revenue of 43.02 crore with a net…
Read the full analysis - Natural Capsules Limited concludes 33rd Annual General Meeting; shareholders deliberate on financial adoption and related party transactionsAGM/EGMlow impact
Cruxal's analysis: Natural Capsules Limited has successfully concluded its 33rd Annual General Meeting held…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.